Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor

被引:82
|
作者
Zoldhelyi, P
McNatt, J
Shelat, HS
Yamamoto, Y
Chen, ZQ
Willerson, JT
机构
[1] Texas Heart Inst, Waf Said Mol Cardiol & Gene Therapy Res Lab, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Dept Med Cardiol, Houston, TX USA
关键词
angioplasty; cerebrovascular disorders; coagulation; genes; thrombosis;
D O I
10.1161/01.CIR.101.3.289
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Tissue factor pathway inhibitor (TFPI) is an endogenous inhibitor of factor Xa and the coagulant initiator complex tissue factor/factor VIIa. Methods and Results-To study the effects of TFPI gene transfer on thrombus formation, balloon-injured porcine carotid arteries were treated locally with an adenovirus encoding human TFPI (Ad-TFPI) or control virus. Gene transfer of TFPI was confirmed by detection of human TFPI in the conditioned medium of porcine carotid arteries kept in culture after in vivo transduction, When carotid flow was measured with Doppler probe 5 days after surgery, cyclic flow variations (CFVs) developed in 7 of 8 control pigs after constriction of the injured carotid artery by 40%, and all control-treated arteries occluded after 70% constriction. In contrast, CFVs were observed in only 1 of 8 Ad-TFPI-treated pigs after 40% constriction, and only 3 of 8 occluded after constriction by 70% (P=0.0027 and P=0.007, respectively). None of the 5 TFPI-transduced arteries open after 70% constriction developed CFVs during an incremental epinephrine infusion. Conclusions-Compared with baseline, systemic hemostatic variables and platelet aggregation were unimpaired, suggesting that TFPI gene transfer can prevent arterial thrombosis in the presence of severe shear stress and without detectable hemostatic impairment.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 15 条
  • [11] Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats
    Todaka, T
    Yokoyama, C
    Yanamoto, H
    Hashimoto, N
    Nagata, I
    Tsukahara, T
    Hara, S
    Hatae, T
    Morishita, R
    Aoki, M
    Ogihara, T
    Kaneda, Y
    Tanabe, T
    STROKE, 1999, 30 (02) : 419 - 426
  • [12] Impact of the tissue factor pathway inhibitor gene on apoptosis in human vascular smooth muscle cells
    Dong, Xia
    Song, Li-ping
    Zhu, Dun-wan
    Zhang, Hai-ling
    Liu, Lan-xia
    Leng, Xi-gang
    GENETICS AND MOLECULAR BIOLOGY, 2011, 34 (01) : 25 - 30
  • [13] Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries
    Yin, XH
    Yutani, C
    Ikeda, Y
    Enjyoji, K
    Ishibashi-Ueda, H
    Yasuda, S
    Tsukamoto, Y
    Nonogi, H
    Kaneda, Y
    Kato, H
    CARDIOVASCULAR RESEARCH, 2002, 56 (03) : 454 - 463
  • [14] HVJ-AVE liposome-mediated Tissue Factor Pathway Inhibitor (TFPI) gene transfer with recombinant TFPI (rTFPI) irrigation attenuates restenosis in atherosclerotic arteries
    Yin, Xinhua
    Fu, Yu
    Yutani, Chikao
    Ikeda, Yoshihiko
    Enjyoji, Keiichi
    Kato, Hisao
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 135 (02) : 245 - 248
  • [15] Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques - Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions
    Badimon, JJ
    Lettino, M
    Toschi, V
    Fuster, V
    Berrozpe, M
    Chesebro, JH
    Badimon, L
    CIRCULATION, 1999, 99 (14) : 1780 - 1787